✦ LIBER ✦

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy

✍ Scribed by Mohamed H Emara; Nahla E El-Gammal; Lamiaa A Mohamed; Maged M Bahgat

Book ID: 119908426
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 264 KB
Volume: 7
Category: Article
ISSN: 1743-422X
DOI: 10.1186/1743-422x-7-324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Therapeutic effects of pegylated interfe

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection

✍ Li-Wei Chen; Rong-Nan Chien; Cho-Li Yen; Jia-Jang Chang; Ching-Jung Liu; Chih-La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Pegylated interferon-alpha 2b–ribavirin

Pegylated interferon-alpha 2b–ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

✍ M. Derbala; A. Amer; A. Bener; A. C. Lopez; M. Omar; M. El Ghannam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Racial differences in neutrophil count i

Racial differences in neutrophil count in chronic hepatitis C patients on pegylated interferon/ribavirin therapy

✍ Temima Markovits; Adedayo Mokuolu; Samuel Daniel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 53 KB

Impact of occult hepatitis B virus infec

Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-α therapy for patients with chronic hepatitis C

✍ Izumi Hasegawa; Etsuro Orito; Yasuhito Tanaka; Noboru Hirashima; Kenji Sakakibar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Iatrogenic hyperpigmentation in chronica

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin

✍ Jennifer Lin; Jason P. Lott; Valerianna K. Amorosa; Carrie L. Kovarik 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB